Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Menu dropdown menu Search search

Search Results for product approval

Sort by:

Recent Relevant
Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize Yuvezzi image

08.20.2026

Lupin and Tenpoint Announce Strategic Partnership to Commercialize Yuvezzi in Europe

Eyewire News
Zeiss Clinic 360 Receives FDA 510k Clearance image

08.19.2026

Zeiss Receives FDA 510k Clearance for Zeiss Clinic 360 Cloud-Based Data Management Solution

Eyewire News

08.18.2026

The Story Behind LYTENAVA™: From FDA Approval to Retina Practice

Barry Kuppermann, MD, PhD; and Bob Jahr, CEO of Outlook Therapeutics

Eyetube link out
Staar Surgical Appoints Warren Foust as President and CEO image

08.05.2026

Staar Surgical Appoints Warren Foust as President and CEO

Eyewire News
Biocon Launches Aflibercept Biosimilar Yesafili in the US image

08.03.2026

Biocon Launches Aflibercept Biosimilar Yesafili in the US

Eyewire News
CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending image

07.28.2026

CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending

Eyewire News
FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD image

07.24.2026

FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD

Eyewire News

07.15.2026

Lineage Advances COR1 Allogeneic Corneal Endothelial Cell Therapy Into Animal Studies

Eyewire News

07.09.2026

Teva, Samsung Bioepis Sign Canadian Commercialization Agreement for Aflibercept Biosimilar

Eyewire News
Samsung Bioepis, Harrow Relaunch Byooviz in US Under New Commercialization Partnership image

07.01.2026

Samsung Bioepis, Harrow Relaunch Byooviz in US Under New Commercialization Partnership

Eyewire News

06.30.2026

FDA Grants Priority Review to Genentech's Supplemental BLA for Enspryng in Thyroid Eye Disease

Eyewire News
Hengrui Pharma Secures China Approval for Water-Free Cyclosporine Eye Drop for Dry Eye Disease image

06.30.2026

Hengrui Pharma Secures China Approval for Water-Free Cyclosporine Eye Drop for Dry Eye Disease

Eyewire News
FDA Approves Viridian's Lumvoa for Thyroid Eye Disease (TED) image

06.26.2026

FDA Approves Viridian's Lumvoa for Thyroid Eye Disease (TED)

Eyewire News
Lenz Therapeutics Licenses Vizz to Arrotex for Australia, New Zealand Commercialization image

06.26.2026

Lenz Therapeutics Licenses Vizz to Arrotex for Australia, New Zealand Commercialization

Eyewire News
Harrow Re-Launches Verkazia for Treatment of Vernal Keratoconjunctivitis image

06.11.2026

Harrow Re-Launches Verkazia for Treatment of Vernal Keratoconjunctivitis

Eyewire News

06.08.2026

FDA Issues Draft Guidance to Accelerate Development of Gene Therapies Using Existing Scientific Knowledge

Eyewire News
Everest Medicines Acquires Greater China Rights to Lenz Therapeutics’ Presbyopia Eye Drop Vizz image

06.08.2026

Everest Medicines Acquires Greater China Rights to Lenz Therapeutics’ Presbyopia Eye Drop Vizz

Eyewire News
Rayner Launches Optiesis Cohesive OVD Family image

06.01.2026

Rayner Launches Optiesis Cohesive OVD in Europe

Eyewire News

05.27.2026

Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Retinal Therapy

Eyewire News
Outlook Therapeutics Wins FDA Appeal for Lytenava, Plans BLA Resubmission in June image

05.26.2026

Outlook Therapeutics Wins FDA Appeal for Lytenava, Plans BLA Resubmission in June

Eyewire News

View More